Secretion of Alzheimer's disease Aβ amyloid peptide by activated human platelets

Laboratory Investigation

Volumn 78, Issue 4, 1998, Pages 461-469

  Li, Qiao Xin ^a,b   Whyte, Scott ^a,b   Tanner, Jane E ^a,b   Evin, Geneviève ^a,b   Beyreuther, Konrad ^c   Masters, Colin L ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CALCIMYCIN; COLLAGEN; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E1; THROMBIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BLOOD CLOTTING; DEGENERATIVE DISEASE; HUMAN; IMMUNOPRECIPITATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

AMYLOID BETA-PROTEIN; BLOOD PLATELETS; HUMANS; PLATELET ACTIVATION;

EID: 0031959497     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Allsop D, Christie G, Gray G, Holmes S, Markwell R, Owen D, Smith L, Wadsworth H, Ward RV, Hartmann T, Lichtenthaler SF, Evin G, Fuller S, Tanner J, Masters CL, Beyreuther B, and Roberts GW (1997). Studies on inhibition of β-amyloid formation in APP751-transfected IMR-32 cells, and SPA4CT-transfected SHSY5Y cells. In: Iqbal K, Winblad B, Nishimura T, Takeda M, and Wisniewski HM, editors: Alzheimer's disease: Biology, diagnosis and therapeutics. West Sussex: John Wiley & Sons, 717-727.
2. Ashall F and Goate AM (1994). Role of the β-amyloid precursor protein in Alzheimer's disease. Trends Biochem Sci 19:42-46.
3. Busciglio J, Gabuzda DH, Matsudaira P, and Yankner BA (1993). Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci U S A 90:2092-2096.
4. Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P, Multhaup G, Beyreuther K, and Masters CL (1990). The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 265:15977-15983.
5. Cai X, Golde TE, and Younkin SG (1993). Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259:514-516.
6. Chen M, Inestrosa NC, Ross GS, and Fernandez HL (1995). Platelets are the primary source of amyloid β-peptide in human blood. Biochem Biophys Res Commun 213:96-103.
7. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, and Selkoe DJ (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-674.
8. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St George Hyslop P, and Selkoe D (1997). Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat Med 3:67-72.
9. Cole GM, Galasko D, Shapiro IP, and Saitoh T (1990). Stimulated platelets release amyloid β-protein precursor. Biochem Biophys Res Commun 170:288-295.
10. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Pereztur J, Mutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, and Younkin S (1996). Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-713.
11. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, and Ward PJ (1990). Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122-1124.
12. Etcheberrigaray R, Ito E, Kim CS, and Alkon DL (1994). Soluble β-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. Science 264:276-279.
13. Fuller SJ, Storey E, Li QX, Smith AI, Beyreuther K, and Masters CL (1995). Intracellular production of βA4 amyloid of Alzheimer's disease: Modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor. Biochemistry 34:8091-8098.
14. Glenner GG and Wong CW (1984). Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
15. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, Suzuki N, and Younkin SG (1995). Amyloid β protein (Aβ) in Alzheimer's disease brain: Biochemical and immunocytoChemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J Biol Chem 270:7013-7016.
16. Haass C, Hung AY, Schlossmacher MG, Teplow DB, and Selkoe DJ (1993). β-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268:3021-3024.
17. Haass C, Hung AY, Selkoe DJ, and Teplow DB (1994). Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J Biol Chem 269:17741-17748.
18. Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, and Selkoe DJ (1995). The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nat Med 1:1291-1296.
19. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, and Selkoe DL (1992). Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325.
20. Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Roberts GW, Allsop D, Masters CL, Dotti CG, Unsicker K, and Beyreuther K (1997). Distinct sites of intracellular production for Alzheimer's disease Aβ40/42-amyloid peptides. Nat Med 3:1016-1020.
21. Hilbich C, Kisters-Woike B, Reed J, Masters CL, and Beyreuther K (1991). Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J Mol Biol 218:149-163.
22. Hilbich C, Mönning U, Grund C, Masters CL, and Beyreuther K (1993). Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J Biol Chem 268:26571-26577.
23. Ida N, Hartmann T, Pantel J, Schroder J, Zerfass R, Forstl H, Sandbrink R, Masters CL, and Beyreuther K (1996). Analysis of heterogeneous β-A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay. J Biol Chem 271:22908-22914.
24. lizuka T, Shoji M, Kawarabayashi T, Sato M, Kobayashi T, Tada N, Kasai K, Matsubara E, Watanabe M, Tomidokoro Y, and Hirai S (1996). Intracellular generation of amyloid β-protein from amyloid β-protein precursor fragment by direct cleavage with β- and γ-secretase. Biochem Biophys Res Commun 218:238-242.
25. Jarrett JT, Berger EP, and Lansbury PT Jr (1993). The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697.
26. Kang J, Lemaire H, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K, Multhaup G, Beyreuther K, and Müller-Hill B (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736.
27. Koo EH and Squazzo SL (1994). Evidence that production and release of amyloid β-protein involves the endocytic pathway. J Biol Chem 269:17386-17389.
28. Kowalska MA and Badellino K (1994). Beta-amyloid protein induces platelet aggregation and supports platelet adhesion. Biochem Biophys Res Commun 205:1829-1835.
29. Lang IM, Moser KM, and Schleef RR (1997). Expression of kunitz protease inhibitor-containing forms of amyloid β-protein precursor within vascular thrombi. Circulation 94: 2728-2734.
30. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, and Tanzi RE (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
31. Li QX, Berndt MC, Bush AI, Rumble B, Mackenzie I, Friedhuber A, Beyreuther K, and Masters CL (1994). Membrane-associated forms of the βA4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: Surface expression on the activated human platelet. Blood 84:133-142.
32. Li QX, Evin G, Small DH, Multhaup G, Beyreuther K, and Masters CL (1995). Proteolytic processing of Alzheimer's disease βA4 amyloid precursor protein in human platelets. J Biol Chem 270:14140-14147.
33. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, and Beyreuther K (1985a). Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757-2763.
34. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, and Beyreuther K (1985b). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249.
35. 2+ homeostasis in Alzheimer's disease. Trends Neurosci 16:409-414.
36. Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS, and Emmerling MR (1996). Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem 271: 20631-20635.
37. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levylahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, and Younkin S (1996). Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2:864-870.
38. Schmaier AH, Dahl LD, Rozemuller AJ, Roos RA, Wagner SL, Chung R, and Van Nostrand WE (1993). Protease nexin-2/ amyloid beta protein precursor: A tight-binding inhibitor of coagulation factor IXa. J Clin Invest 92:2540-2545.
39. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thai LJ, Lieberburg I, and Schenk DB (1993). Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361:260-263.
40. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindleshurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, and Schenk D (1992). Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327.
41. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinnessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, and St George Hyslop PH (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
42. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai X, McKay DM, Tintner R, Frangione B, and Younkin SG (1992). Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258:126-129.
43. Simons M, de Strooper B, Multhaup G, Tienari PJ, Dotti CG, and Beyreuther K (1996). Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J Neurosci 16:899-908.
44. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, and Price DL (1990). Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495.
45. Smith RP and Broze GJ Jr (1992). Characterization of platelet-releasable forms of β-amyloid precursor proteins: The effect of thrombin. Blood 80:2252-2260.
46. a-inhibitor, a form of Alzheimer amyloid precursor protein. Science 248:1126-1128.
47. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, Golde TE, and Younkin SG (1994). An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264:1336-1340.
48. Thomas T, Thomas G, Mclendon C, Sutton T, and Mullan M (1996). β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380:168-171.
49. Tienari PJ, Ida N, Ikonen E, Simons M, Weidemann A, Multhaup G, Master CL, Dotti CG, and Beyreuther K (1997). Intracellular and secreted Alzheimer's β-amyloid species are generated by distinct mechanisms in the cultured hippocampal neurons. Proc Natl Acad Sci U S A 94:4125-4130.
50. Turner RS, Suzuki N, Chyung ASC, Younkin SG, and Lee VMY (1996). Amyloids β40 and β42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J Biol Chem 271:8966-8970.
51. Urmoneit B, Prikulis I, Wihl G, D'Urso D, Frank R, Heeren J, Beisiegel U, and Prior R (1997). Cerebrovascular smooth muscle cells internalize Alzheimer's amyloid beta protein via a lipoprotein pathway: Implications for cerebral amyloid angiopathy. Lab Invest 77:157-166.
52. Van Nostrand WE, Schmaier AH, Farrow JS, Cines DB, Cunningham DD (1991). Protease nexin-2/amyloid β-protein precursor in blood is a platelet-specific protein. Biochem Biophys Res Commun 175:15-21.
53. Van Nostrand WE, Schmaler AH, Farrow JS, Cunningham DD (1990). Protease nexin-II (amyloid β-protein precursor): A platelet α-granule protein. Science 248:745-748.
54. Weidemann A, König G, Bunke D, Fischer P, Salbaum JM, Masters CL, and Beyreuther K (1989). Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57:115-126.
55. Whyte S, Wilson N, Currie J, Maruff P, Malone V, Shafiq-Antonacci R, Tyler P, Derry KL, Underwood J, Li Q-X, Beyreuther K, and Masters CL (1997). Collection and normal levels of the amyloid precursor protein in plasma. Ann Neurol 41:121-124.
56. Wild-Bode C, Yamazaki T, Capell A, Leimer U, Steiner H, Ihara Y, and Haass C (1997). Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42. J Biol Chem 272:16085-16088.
57. Xu H, Sweeney D, Wang R, Thinakaran G, Lo ACY, Sisodia SS, Greengard P, and Gandy S (1997). Generation of Alzheimer's β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci U S A 94:3748-3752.
58. Yankner BA, Duffy LK, and Kirschner DA (1990). Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250:279-282.